{"id":"intravenous-nitroglycerin","safety":{"commonSideEffects":[{"rate":"10-20","effect":"Headache"},{"rate":"5-15","effect":"Hypotension"},{"rate":"5-10","effect":"Tachycardia"},{"rate":"5-10","effect":"Dizziness"},{"rate":"2-5","effect":"Nausea"},{"rate":"<1","effect":"Methemoglobinemia (with prolonged use)"}]},"_chembl":{"chemblId":"CHEMBL730","moleculeType":"Small molecule","molecularWeight":"227.08"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Nitroglycerin is metabolized to nitric oxide, which activates guanylate cyclase and increases cyclic GMP levels in vascular smooth muscle cells, leading to vasodilation. This reduces venous return (preload) and systemic vascular resistance (afterload), decreasing myocardial oxygen demand and improving coronary blood flow. The intravenous formulation provides rapid onset and precise titration for acute hemodynamic management.","oneSentence":"Intravenous nitroglycerin is a nitrate vasodilator that releases nitric oxide to relax vascular smooth muscle and reduce preload and afterload on the heart.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:49:53.116Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute angina pectoris"},{"name":"Acute myocardial infarction with chest pain"},{"name":"Hypertensive crisis"},{"name":"Acute heart failure with pulmonary edema"},{"name":"Perioperative hypertension"}]},"trialDetails":[{"nctId":"NCT06682260","phase":"PHASE4","title":"Evaluating the Effects of Nitroglycerin on Heart Function and Urinary Output in Patients With Acute Heart Failure","status":"COMPLETED","sponsor":"Copenhagen University Hospital, Hvidovre","startDate":"2025-02-01","conditions":"Acute Heart Failure (AHF)","enrollment":21},{"nctId":"NCT06783296","phase":"NA","title":"Efficacy and Safety of Renal Denervation on Isolated Diastolic Hypertension","status":"NOT_YET_RECRUITING","sponsor":"Shanghai 10th People's Hospital","startDate":"2026-01-01","conditions":"Hypertension, Renal Denervation Therapy","enrollment":124},{"nctId":"NCT02425566","phase":"PHASE1","title":"Role of Sympathetic Activity and Splanchnic Capacitance in Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University","startDate":"2015-04","conditions":"Hypertension","enrollment":12},{"nctId":"NCT06896903","phase":"NA","title":"Analysis of Coronary Reactivity Testing With and Without Intracoronary Nitrate Testing","status":"RECRUITING","sponsor":"Baylor Research Institute","startDate":"2025-05-21","conditions":"ANOCA - Angina With Non-obstructive Coronary Arteries, INOCA (Ischemia With Non Obstructive Coronary Artery Disease)","enrollment":50},{"nctId":"NCT05031520","phase":"","title":"PericOronary INflammaTion in Non-Obstructive Coronary Artery Disease","status":"TERMINATED","sponsor":"NYU Langone Health","startDate":"2021-07-12","conditions":"Non-Obstructive Coronary Atherosclerosis","enrollment":32},{"nctId":"NCT05393882","phase":"","title":"Impact of Cholesterol Level on Long-term Coronary Bypass Graft Patency","status":"WITHDRAWN","sponsor":"Chinese University of Hong Kong","startDate":"2025-09","conditions":"Coronary Artery Disease, Bypass Graft Stenosis, Dyslipidemias","enrollment":""},{"nctId":"NCT06028672","phase":"NA","title":"Toripalimab Plus Actinomycin-D as Fist-Line Treatment for GTN With FIGO Score 5-6","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2023-09-12","conditions":"Gestational Trophoblastic Neoplasia","enrollment":40},{"nctId":"NCT06020755","phase":"PHASE2","title":"Toripalimab Plus Actinomycin-D As Fist-Line Treatment for GTN with FIGO Score 7","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2024-12","conditions":"Gestational Trophoblastic Neoplasia","enrollment":17},{"nctId":"NCT05122780","phase":"PHASE4","title":"Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-07-01","conditions":"Myocardial Infarction With Non-Obstructive Coronary Arteries","enrollment":120},{"nctId":"NCT06265415","phase":"NA","title":"Comparative Study of Intravenous Labetalol Versus Intravenous Nitroglycerin Versus Sublingual Nifedipine","status":"UNKNOWN","sponsor":"Sohag University","startDate":"2024-03-30","conditions":"Severe Preeclampsia","enrollment":60},{"nctId":"NCT03251599","phase":"PHASE4","title":"The Effect of Nitroglycerin Infusion Rate on Cerebral Rewarming During Hypothermic Coronary Artery Bypass Grafting","status":"COMPLETED","sponsor":"Recep Tayyip Erdogan University","startDate":"2017-08-16","conditions":"Coronary Artery Bypass, Cardiopulmonary Bypass","enrollment":78},{"nctId":"NCT04564521","phase":"NA","title":"Nitroglycerin for Intra-arterial Chemotherapy in Pediatric Retinoblastoma.","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2020-09-28","conditions":"Retinoblastoma","enrollment":36},{"nctId":"NCT04221594","phase":"","title":"Quantification of Myocardial Blood Flow Using Dynamic PET/CTA Fused Imagery","status":"COMPLETED","sponsor":"Emory University","startDate":"2019-11-01","conditions":"Coronary Artery Disease","enrollment":68},{"nctId":"NCT05814991","phase":"","title":"A Cohort Prospective Study of Predictors Influencing the Quality of Visualization of the Operating Field During Orthognathic Surgery","status":"ENROLLING_BY_INVITATION","sponsor":"State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia","startDate":"2023-05-29","conditions":"Malocclusion, Maxillofacial Injuries, Orthodontics","enrollment":100},{"nctId":"NCT04953156","phase":"","title":"Nitroglycerine Versus Dexmedetomidine Infusion in Intraoperative Management of Uncontrolled Hypertension","status":"COMPLETED","sponsor":"National Cancer Institute, Egypt","startDate":"2021-07-03","conditions":"Hypertension","enrollment":77},{"nctId":"NCT02209636","phase":"PHASE4","title":"Phosphate Lowering in CKD Trial","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2014-09-15","conditions":"Chronic Kidney Disease, Cardiovascular Disease","enrollment":66},{"nctId":"NCT05442931","phase":"PHASE1, PHASE2","title":"Comparison Between Pregabalin and Magnesium Sulfate in Hypotensive Anaesthesia","status":"UNKNOWN","sponsor":"Minia University","startDate":"2022-05-01","conditions":"Functional Endoscopic Sinus Surgery","enrollment":60},{"nctId":"NCT03338504","phase":"","title":"Determining the Mechanism of Myocardial Injury and Role of Coronary Disease in Type 2 Myocardial Infarction","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2017-10-23","conditions":"Myocardial Infarction, Acute, Myocardial Ischemia, Myocardial Injury","enrollment":100},{"nctId":"NCT04756713","phase":"PHASE3","title":"Second Uterine Evacuation for Low-risk Gestational Trophoblastic Neoplasia","status":"UNKNOWN","sponsor":"Brigham and Women's Hospital","startDate":"2021-02-11","conditions":"Gestational Trophoblastic Neoplasia, Molar Pregnancy, Gestational Trophoblastic Tumor, Non-Metastatic","enrollment":150},{"nctId":"NCT05310929","phase":"NA","title":"Nitroglycerin Versus Labetalol in Acute Severe Pre-eclampsia","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2019-08-28","conditions":"Severe Pre-eclampsia","enrollment":200},{"nctId":"NCT05241054","phase":"NA","title":"Effect of Local Anesthesia Versus Induced Hypotensive Anesthesia on Quality of External Dacryocystorhinostomy Operation","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2022-03","conditions":"Patient With Nasolacrimal Duct Obstruction, External Dacryocystorhinostomy Operation","enrollment":64},{"nctId":"NCT04594629","phase":"PHASE1","title":"PGI2 Versus Nitroglycerine for Management of Pulmonary Hypertension After Valve Surgeries","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2020-11","conditions":"Pulmonary Hypertension","enrollment":120},{"nctId":"NCT03357731","phase":"PHASE2","title":"A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2017-11-30","conditions":"Heart Failure, Cardiac Failure, Reduced Ventricular Ejection Fraction","enrollment":49},{"nctId":"NCT02265965","phase":"PHASE4","title":"Trial of IV NTG for CD After Second Stage Arrest for the Prevention of Uterine Extension","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2015-10","conditions":"Prolonged Second Stage of Labor","enrollment":18},{"nctId":"NCT01999517","phase":"PHASE4","title":"Contrast Nephropathy and Nitrates","status":"COMPLETED","sponsor":"Mt. Sinai Medical Center, Miami","startDate":"2013-06","conditions":"Contrast Induced Nephropathy","enrollment":122},{"nctId":"NCT04008732","phase":"PHASE1","title":"Evaluating MED2005 & Nitrostat Bioavailability","status":"COMPLETED","sponsor":"Futura Medical Developments Ltd.","startDate":"2017-11-15","conditions":"Erectile Dysfunction","enrollment":40},{"nctId":"NCT03885388","phase":"PHASE2, PHASE3","title":"Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma （GTN） Patients With Score of 5-6","status":"UNKNOWN","sponsor":"Women's Hospital School Of Medicine Zhejiang University","startDate":"2019-03-08","conditions":"Gestational Trophoblastic Tumor, Effects of Chemotherapy, Drug Toxicity","enrollment":300},{"nctId":"NCT00838695","phase":"NA","title":"Variability in Adrenergic Response","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2009-01","conditions":"Vascular Reaction to Medications","enrollment":106},{"nctId":"NCT03422354","phase":"NA","title":"Effect of Ultrasound Guided L1,L2 Paravertebral Block in Decrease the Requirements for Hypotensive Drugs During General Anesthesia in Patients Undergoing Hip Surgeries.","status":"COMPLETED","sponsor":"Cairo University","startDate":"2018-02-12","conditions":"Ultrasound Guided L1,L2 Paravertebral Block","enrollment":74},{"nctId":"NCT03422913","phase":"NA","title":"Controlled Low Central Venous Pressure Combined With Hilar Block in Laparoscopic Hepatectomy","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2017-07-01","conditions":"Laparoscopic Hepatectomy","enrollment":140},{"nctId":"NCT02327793","phase":"PHASE2","title":"Perfusion and Antihypertensive Therapy in Acute Ischemic Stroke","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2009-06","conditions":"Stroke, Acute","enrollment":65},{"nctId":"NCT02115256","phase":"PHASE2, PHASE3","title":"Study to Evaluate is ECV Success is Improved and the Side Effects Reduced With the Use of IV NTGL Versus Terbutaline","status":"TERMINATED","sponsor":"Yaakov Beilin","startDate":"2014-07","conditions":"External Cephalic Version","enrollment":6},{"nctId":"NCT00759707","phase":"NA","title":"Endothelial Function in Lower Extremity Bypass Grafts","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2006-04","conditions":"Peripheral Arterial Disease","enrollment":19},{"nctId":"NCT00762242","phase":"","title":"Metabolomic Profiling of Novel Mediators of Vascular Function","status":"TERMINATED","sponsor":"Brigham and Women's Hospital","startDate":"2007-05","conditions":"Type 2 Diabetes Mellitus","enrollment":48},{"nctId":"NCT01785589","phase":"PHASE4","title":"Validation of Myocardial Perfusion Imaging","status":"COMPLETED","sponsor":"University Hospital, Grenoble","startDate":"2012-05","conditions":"Coronary Artery Disease","enrollment":220},{"nctId":"NCT00803634","phase":"PHASE3","title":"Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure (PRONTO)","status":"COMPLETED","sponsor":"The Medicines Company","startDate":"2008-12","conditions":"Hypertension, Heart Failure","enrollment":117},{"nctId":"NCT00716079","phase":"NA","title":"The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial","status":"COMPLETED","sponsor":"The George Institute","startDate":"2008-09","conditions":"Intracerebral Hemorrhage, Stroke, Hypertension","enrollment":2839},{"nctId":"NCT00896311","phase":"NA","title":"Intravenous (IV) Nitroglycerin for Versions in Nulliparous Women","status":"COMPLETED","sponsor":"University of Calgary","startDate":"2003-03","conditions":"Breech Presentation, Complication of Pregnancy","enrollment":82},{"nctId":"NCT00901758","phase":"NA","title":"Intravenous (IV) Nitroglycerin for Versions in Multiparous Women","status":"COMPLETED","sponsor":"University of Calgary","startDate":"2003-03","conditions":"Breech Presentation, Pregnancy Complication","enrollment":44},{"nctId":"NCT00795678","phase":"","title":"Chemotherapeutic Agents in Brain/Breast","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2008-09","conditions":"Breast Cancer, Metastatic Cancer","enrollment":10},{"nctId":"NCT00682370","phase":"PHASE1","title":"Effects of Heme Arginate in Healthy Male Subjects","status":"COMPLETED","sponsor":"Daniel Doberer","startDate":"2007-10","conditions":"Healthy Subjects, Heme Oxygenase, Genetic Polymorphism","enrollment":15},{"nctId":"NCT00270374","phase":"PHASE3","title":"A Study Comparing Blood Flow and Clinical and Safety Effects of the Addition of Natrecor (Nesiritide), Placebo or Intravenous Nitroglycerin to Standard Care for the Treatment of Worsening Congestive Heart Failure.","status":"COMPLETED","sponsor":"Scios, Inc.","startDate":"1999-10","conditions":"Symptomatic Decompensated Congestive Heart Failure, Congestive Heart Failure in Acute Coronary Syndrome","enrollment":498},{"nctId":"NCT00707928","phase":"PHASE4","title":"Intravenous Nitroglycerin for Retained Placenta Extraction: a Multicenter Study","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2008-02","conditions":"Retained Placenta","enrollment":100},{"nctId":"NCT01162824","phase":"NA","title":"Blood Markers for Inflammation and Coronary Artery Vasoreactivity Testing in Patients With Chest Pain and Normal Coronary Arteries","status":"UNKNOWN","sponsor":"St George's Healthcare NHS Trust","startDate":"2011-01","conditions":"Endothelial Dysfunction, Atherosclerosis, Inflammation","enrollment":50},{"nctId":"NCT00810381","phase":"NA","title":"Ocular Hemodynamic Effects of Nitrovasodilators in Healthy Subjects","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"1999-01","conditions":"Glaucoma","enrollment":14},{"nctId":"NCT00431691","phase":"PHASE4","title":"Effect of Antioxidants on Ocular Blood Flow, Endothelial Function, and Cytokine Levels in LPS Induced Inflammatory Model in Humans.","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2006-09","conditions":"Retina, Regional Blood Flow, Endotoxin, Escherichia Coli","enrollment":22},{"nctId":"NCT00264186","phase":"PHASE1","title":"Recombinant Human Superoxide Dismutase (rhSOD) and Vascular Reactivity","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2005-06","conditions":"Inflammation","enrollment":43},{"nctId":"NCT00335010","phase":"NA","title":"Intravenous NTG to Preserve Gastric Microcirculation During Gastric Tube Reconstruction","status":"COMPLETED","sponsor":"Erasmus Medical Center","startDate":"2005-05","conditions":"Esophageal Neoplasms, Microcirculation","enrollment":32}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":642,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"intravenous nitroglycerin","genericName":"intravenous nitroglycerin","companyName":"University of California, San Francisco","companyId":"university-of-california-san-francisco","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Intravenous nitroglycerin is a small molecule that activates soluble guanylate cyclase, a molecular target involved in vascular function. It has been studied in various clinical trials for conditions such as type 2 diabetes mellitus, contrast-induced nephropathy, and severe pre-eclampsia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}